Motif ID: Sox5_Sry
Z-value: 1.499


Transcription factors associated with Sox5_Sry:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Sox5 | ENSMUSG00000041540.10 | Sox5 |
Sry | ENSMUSG00000069036.3 | Sry |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sox5 | mm10_v2_chr6_-_143947061_143947088 | 0.45 | 3.2e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
4.0 | 15.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
2.9 | 32.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.6 | 20.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.5 | 9.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
1.2 | 4.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.0 | 6.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.8 | 4.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.8 | 3.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.8 | 3.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.8 | 2.3 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.7 | 2.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.7 | 5.6 | GO:0061368 | maternal process involved in parturition(GO:0060137) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 4.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.6 | 3.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 1.9 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.6 | 4.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 5.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.6 | 6.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.6 | 3.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 1.7 | GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
0.6 | 4.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 1.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 6.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 1.5 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.5 | 1.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.5 | 1.9 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.5 | 10.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 3.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 6.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 2.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 6.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 1.6 | GO:0061428 | embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 2.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 2.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.4 | 2.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 3.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 15.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 6.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.4 | 2.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 3.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 0.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 1.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.3 | 1.0 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.3 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.3 | 1.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.2 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.3 | 2.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 2.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 2.6 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 3.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 1.4 | GO:0042891 | antibiotic transport(GO:0042891) dipeptide transport(GO:0042938) |
0.3 | 3.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 2.5 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 1.8 | GO:0035826 | rubidium ion transport(GO:0035826) cellular hypotonic response(GO:0071476) |
0.2 | 1.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 4.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.7 | GO:0097278 | transforming growth factor beta activation(GO:0036363) complement-dependent cytotoxicity(GO:0097278) |
0.2 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 3.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.6 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.2 | 0.6 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.2 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 2.6 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 2.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 1.1 | GO:0090494 | positive regulation of sphingolipid biosynthetic process(GO:0090154) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 1.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.3 | GO:0060066 | regulation of anagen(GO:0051884) oviduct development(GO:0060066) |
0.1 | 2.7 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.6 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.1 | 0.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.7 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 3.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 1.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 2.6 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 2.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.5 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 2.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 3.6 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.8 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 3.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 2.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 4.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 1.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.7 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 2.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 1.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 11.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 2.2 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 1.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:1900169 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 1.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 3.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 2.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 1.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 8.3 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 1.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 1.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.2 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.0 | 1.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 1.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 3.5 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:2000643 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 2.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 1.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 1.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 10.0 | GO:0031673 | H zone(GO:0031673) |
1.6 | 32.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 4.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.8 | 15.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 2.3 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.5 | 4.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 4.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.9 | GO:0044305 | calyx of Held(GO:0044305) |
0.3 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 3.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 1.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 4.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
0.3 | 1.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 5.4 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 3.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 4.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 6.2 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 2.1 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 4.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 17.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 2.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 3.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 1.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 5.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 4.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 3.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 4.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 3.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.6 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 1.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 30.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 3.8 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 1.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 5.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 2.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 6.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 5.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 3.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 1.8 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 2.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.9 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 1.2 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 4.7 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 1.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 4.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.6 | 11.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.5 | 6.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.3 | 18.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.1 | 4.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.9 | 6.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 4.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.7 | 14.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 14.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 4.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 37.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 3.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.6 | 2.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.5 | 3.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 3.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 2.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.5 | 1.9 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.5 | 1.4 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.5 | 6.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 1.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 3.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 14.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 2.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 2.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 17.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 2.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 4.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.9 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.2 | 1.2 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.2 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 4.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 6.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 3.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 5.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 6.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 2.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.7 | GO:0002135 | CTP binding(GO:0002135) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.0 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 26.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 3.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 7.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 1.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.2 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 6.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 1.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 5.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 2.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 2.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 19.6 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.3 | 5.8 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.3 | 18.7 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.3 | 15.9 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 17.4 | PID_FGF_PATHWAY | FGF signaling pathway |
0.2 | 1.6 | PID_FOXO_PATHWAY | FoxO family signaling |
0.2 | 6.3 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 14.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.5 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.1 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 5.5 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.1 | 1.0 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.7 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.9 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.0 | 2.1 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 1.2 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.0 | 3.0 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.4 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 4.2 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.0 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.9 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.0 | 1.0 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.7 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.6 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.0 | 0.9 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.4 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.8 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 32.3 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 15.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 2.8 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.2 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 6.2 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 13.6 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.2 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.7 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 4.7 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.9 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 2.1 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.2 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.6 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 7.3 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.6 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 9.2 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.8 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.1 | 3.7 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.4 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.4 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.7 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.9 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 2.8 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.0 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.8 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.2 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 4.3 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.6 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 2.0 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 1.1 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 2.9 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.6 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.5 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 1.0 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.7 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.4 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |